Our portfolio includes a wide variety of standardized botanical extracts and active pharmaceutical ingredients (API).
Our innovation strategy is divided between our internal Research & Development department and the partner company Phytobios, which has a complementary approach focused on radical innovation from Brazilian biodiversity.
For the formulation of cosmetics, we attend the personal care market with large capacity to supply extracts and essential oils.
Our extracts for the veterinary industry preserve the main constituents necessary for the maintenance of animal health.
From botanical extracts to dehydrated fruit juices and pulps, we offer a complete product line for the food & beverages industry, manufactured from selected raw materials and structured processes.

In the 60 years of Centroflora Group’s history, we have always integrated important assets into our company:
communities, nature, processes and, above all, people. Here we produce:

  • Botanical extracts;
  • Dehydrated juices and pulps;
  • Essential oils;
  • Isolated inputs;


Learn more about the Jaborandi production chain, a Brazilian plant used for the manufacture of Pilocarpine, which is an API widely used by the pharmaceutical industry. The program annually benefits hundreds of families in three states through the generation of income from the sustainable collection of jaborandi leaves and through enabling direct purchases from the communities involved. In 2015, Centroflora won the National Biodiversity Award in recognition of this program.


Stay up to date on everything that happens at Centroflora Group,
including latest releases, projects and detailed information about our products.

Launch of Good Agricultural Practices Manual is the highlight of Centroflora’s Annual Partner Producer meeting

The Annual Partner Producer meeting, organized by Centroflora Group, took place on November 27th  and gathered producers from the states of São Paulo and Paraná that…


Centroflora Group is interviewed by Pharma Horizon during the CPhI in Germany. Check out!

Centroflora’s innovation was once again in the spotlight. Pharma Horizon interviewed three key executives of our company – CEO Peter Andersen, Chief Technology & Scientific Officer…


Centroflora CMS is now C² PHARMA

New branding emphasizes the company’s focus on the pharma sector. Effective on October 19th of 2017, Centroflora CMS, joint venture between Centroflora Group and CMS pharma,…


Established to promote the development of family agriculture, sustainable management and conservation of biodiversity, the program generates benefits for all involved:

Centroflora Group



CENTROFLORA 2017 © | All rights reserved